Trial Profile
Clinical Trials Insight: 700031139
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 04 Mar 2008
Price :
$35
*
At a glance
- Drugs Tanespimycin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Kosan Biosciences
- 04 Mar 2008 New trial record.